Veozah (fezolinetant) is a prescription treatment option for hot flashes and night sweats due to menopause. It belongs to the drug class called neurokinin 3 (NK3) receptor antagonists. Veozah (fezolinetant) is a hormone-free tablet that's usually taken by mouth once a day. Side effects include stomach pain, diarrhea, and trouble sleeping. Because of the risk for liver injury, this medication isn't recommended if you have long-term liver damage.
Moderate-to-severe hot flashes and night sweats due to menopause
Veozah (fezolinetant) is a neurokinin 3 (NK3) receptor antagonist. It blocks a chemical in the brain called neurokinin B from causing hot flashes (episodes of sweating and feeling hot).
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Only taken once a day
Works well to lessen how often you have hot flashes from menopause and lower how severe your symptoms are
Hormone-free treatment option
Can take with or without food
Brand name only
Might cause unpleasant side effects, like stomach pain, diarrhea, and back pain
Requires lab work every few months for the first 9 months to check liver health
Not recommended for people with severe kidney or liver problems
Swallow Veozah (fezolinetant) tablets whole with a drink. Don't cut, crush, or chew the tablets because this could damage the medication.
Take Veozah (fezolinetant) at the same time every day so the amount of medication in your body stays consistent.
Before you start Veozah (fezolinetant), your prescriber will order lab work to check your liver health. Once you start the medication, you'll continue to need lab work done every 3 months until the 9th month of treatment. Veozah (fezolinetant) can sometimes affect the liver, so these lab tests help check that the medication is safe for you to take.
If you miss a dose of Veozah (fezolinetant), take it as soon as possible. If your next dose is less than 12 hours away, skip the missed dose and continue with your normal dosing schedule.
Avoid alcohol, spicy foods, and caffeine since these could make hot flashes worse. Speak with your healthcare team about other ways you can try to relieve hot flashes.
Veozah (fezolinetant) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
In clinical studies, some people who took Veozah (fezolinetant) had results on their blood tests that showed higher liver enzyme levels, which can be a sign that the liver is irritated or damaged. Among those who had these abnormal lab results, most people didn't have noticeable symptoms of liver damage. Lab results generally returned to usual when people continued taking, paused, or stopped the medication altogether.
To be safe, your prescriber will order blood tests before you start Veozah (fezolinetant) to check the health of your liver. You'll also need to have your blood tested every 3 months after you start this medication until the 9th month of treatment. Get medical attention right away if you experience signs of liver damage, such as nausea, vomiting, stomach pain, or yellowing of the skin or whites of the eyes.
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
45mg | 30 tablets | $478.29 | $15.94 |
The typical dose is 45 mg by mouth once a day.
Currently have long-term liver damage (cirrhosis)
Currently have severe kidney problems or end-stage kidney disease
Take medications known as CYP1A2 inhibitors
Moderate-to-severe hot flashes and night sweats due to menopause
Moderate-to-severe symptoms of menopause (hot flashes and night sweats)
Prevention of osteoporosis in women who've reached menopause
Moderate-to-severe vasomotor symptoms (VMS) during menopause, including hot flashes and night sweats
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Astellas Pharma US, Inc. (2023). VEOZAH- fezolinetant tablet, film coated [package insert]. DailyMed.
Jayasena, C. N., et al. (2015). Neurokinin B administration induces hot flushes in women. Scientific Reports.
Johnson, K.A., et al. (2023). Efficacy and safety of fezolinetant in moderate to severe vasomotor symptoms associated with menopause: A phase 3 RCT. The Journal of Clinical Endocrinology & Metabolism.
Lu, J., et al. (2020). New insights of CYP1A in endogenous metabolism: A focus on single nucleotide polymorphisms and diseases. Acta Pharmaceutica Sinica B.
National Institute on Aging. (2021). Hot flashes: What can I do?
The North American Menopause Society. (n.d.). Drink to your health at menopause, or not?
U.S. Food and Drug Administration. (2023). For healthcare professionals | FDA’s examples of drugs that interact with CYP enzymes and transporter systems.
U.S. Food and Drug Administration. (2023). FDA approves novel drug to treat moderate to severe hot flashes caused by menopause.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.